| Clinical Bottom Line: When asthma is severe enough to have required an A&E visit, stepped care triggered by peak flow measurements reduces re-visits to A&E over the next 6 months (NNT = 4) |
Cowie RL, Revitt SG, Underwood MF, Field SK: The effect of a peak flow-based action plan in the prevention of exacerbations of asthma. Chest 1997;112:1534-8.
Appraised by: Sackett at the CEBM; Sunday, March 01, 1998
Three-part Question: In asthma patients seen in A&E, would triggering subsequent self-Rx on the basis of peak-flow reduce subsequent visits and hospitalisations?
Search Terms: found on routine EBMJ surveillance
The Study:
Non-blinded concealed randomised controlled trial with intention-to-treat.
Adolescent or adult asthmatics severe enough to have required A&E treatment (beta-agonist by aerosol +/- oral/parenteral steroid.
Control group (combined N = 93; 93 analysed): 1. regular care & 2. stepped care (increased inhaled steroid, then oral prednisone, then to A&E) with steps based on increasing symptoms and failure to obtain >30-120 minutes relief from beta-agaonists.
Experimental group (N = 46; 46 analysed): Stepped care plus 45 minutes instruction (by nurse) in use of Wright peak-flow meter, with doubling inhaled steroid at =<70% predicted or =>20% diurnal variation; oral prednisone at =<50% and to A&E at =<30%.
The Evidence:
|
Outcome |
Time to Outcome |
CER |
EER |
RRR |
ARR |
NNT |
|
A&E visit for urgent asthma treatment |
6 months |
0.355 |
0.109 |
69% |
0.246 |
4 |
|
95% Confidence Intervals: |
32% to 100% |
0.113 to 0.379 |
3 to 9 |
|||
|
Admitted for asthma |
6 months |
0.086 |
0.043 |
50% |
0.043 |
23 |
|
95% Confidence Intervals: |
-45% to 100% |
-0.039 to 0.125 |
NNT = 8 to INF NNH = 26 to INF; |
Comments:
Expiry date: 1 Jan1999
Click here to comment on this CAT |
![]() |